{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:38:40Z","timestamp":1778542720726,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1378\/chest.121.2.656","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T20:09:19Z","timestamp":1055534959000},"page":"656-659","source":"Crossref","is-referenced-by-count":43,"title":["Pulmonary Edema Caused by Inhaled Nitric Oxide Therapy in Two Patients With Pulmonary Hypertension Associated With the CREST Syndrome"],"prefix":"10.1016","volume":"121","author":[{"given":"Ioana R.","family":"Preston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Houtchens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.121.2.656_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(83)91169-5","article-title":"Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis","volume":"75","author":"Ungerer","year":"1983","journal-title":"Am J Med"},{"key":"10.1378\/chest.121.2.656_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-86-4-394","article-title":"Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)","volume":"86","author":"Salerni","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.121.2.656_bib3","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X","article-title":"Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin)","volume":"42","author":"Klings","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.121.2.656_bib4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1183\/09031936.99.13613579","article-title":"Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study","volume":"13","author":"Humbert","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.121.2.656_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.121.2.656_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1183\/09031936.98.12020265","article-title":"Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension","volume":"12","author":"Sitbon","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.121.2.656_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0002-9149(94)90496-0","article-title":"Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure","volume":"74","author":"Bocchi","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.121.2.656_bib8","first-page":"1195","article-title":"Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma","volume":"26","author":"Farber","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.121.2.656_bib9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1378\/chest.118.4.1077","article-title":"Hemodynamic effects of epoprostenol in patients with systemic sclerosis and pulmonary hypertension","volume":"118","author":"Strange","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.121.2.656_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.121.2.656_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1529-0131(200003)43:3<699::AID-ANR28>3.0.CO;2-O","article-title":"Pulmonary edema complicating prostacyclin therapy in pulmonary hypertension associated with scleroderma: a case of pulmonary capillary hemangiomatosis","volume":"43","author":"Gugnani","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.121.2.656_bib12","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1164\/ajrccm.157.5.9708065","article-title":"Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis","volume":"157","author":"Humbert","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.121.2.656_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00005344-199911000-00018","article-title":"Left ventricular chamber function during inhaled nitric oxide in patients with dilated cardiomyopathy","volume":"34","author":"Hayward","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1378\/chest.121.2.656_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1378\/chest.113.1.237","article-title":"Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease","volume":"113","author":"Palmer","year":"1998","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216354812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216354812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T16:55:28Z","timestamp":1553100928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216354812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0012369216354812"],"URL":"https:\/\/doi.org\/10.1378\/chest.121.2.656","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}